A Novel Serum Biomarker, Clusterin, And Related Predictive Index Scoring Could Be An Early Predictor Of Response To Sorafenib In Patients With Advanced Hepatocellular Carcinoma.
HEPATOLOGY(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
HEPATOLOGY(2020)